Boehringer Ingelheim
x

Before You Go...

Tell us why you decided not to register to help us improve

x

Non-Hcp Registraion

Help us understanding your current clinical practice in the management of CKD patients by answering 3 questions:

In approximately what percentage of your T2D patients do you test eGFR within the first year of diagnosis?

Required.

In approximately what percentage of your T2D patients do you test UACR within the first year of diagnosis?

Required.

For which CKD patient populations would you consider an SGLT2 inhibitor as part of the clinical management strategy? Select all that apply.

Required.

x

Help us understanding your current clinical practice in the management of CKD patients by answering 3 questions:

In approximately what percentage of your T2D patients do you test eGFR within the first year of diagnosis?

Required.

In approximately what percentage of your T2D patients do you test UACR within the first year of diagnosis?

Required.

For which CKD patient populations would you consider an SGLT2 inhibitor as part of the clinical management strategy? Select all that apply.

Required.

Mobile_banner_kydney_cornerstone
Unlocking the Next Chapter of the Kidney Care

Unlocking the Next Chapter of Kidney Care

EMPROVING Outcomes in Chronic Kidney Disease

Speakers

Speakers

prof-sarah-jarvis

Prof Sarah Jarvis

General Practitioner (GP)
GP trainer and Fellow of the Royal College of General Practitioners 

Prof chritopher wanner

Prof Christoph Wanner

Professor of Medicine
Head of the Division of Nephrology at the University Hospital of Würzburg, Germany

EMPROVING Outcomes in Chronic Kidney Disease

Webinar ID: 952 3841 8220

August 15, 2024 (Thursday) Time: 18:00:00-19:30:00

Agenda

TimeTopicSpeaker
6:00 PMOpening RemarksDr Allen Costales
(Boehringer Ingelheim)
6:05 PMFaculty Introductions and Scientific AgendaProf Sarah Jarvis
6:10 PMCheck point #1: Evidence & Practice Interactive SessionProf Sarah Jarvis
6:20 PMCase Discussion: CKD Unmasked - The Quest for Early DetectionProf Sarah Jarvis
6:35 PMRevolutionizing Early CKD Protection with SGLT2iProf Christoph Wanner
7:00 PMClinical Practice session: Putting Guidelines to Patient benefitProf Sarah Jarvis
Prof Christoph Wanner
7:20 PMQ & A​Prof Sarah Jarvis
Prof Christoph Wanner
7:30 PM5 Key Takeaways and Closing Remarks​Prof Sarah Jarvis